BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25498159)

  • 1. Primary angiomatoid melanoma as an exceptional morphologic pattern in cutaneous melanoma. A case report and review of the literature.
    Ramos-Rodríguez G; Ortiz-Hidalgo C
    Actas Dermosifiliogr; 2015 Apr; 106(3):e13-7. PubMed ID: 25498159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.
    Granter SR; Weilbaecher KN; Quigley C; Fletcher CD; Fisher DE
    Am J Dermatopathol; 2001 Jun; 23(3):185-9. PubMed ID: 11391097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100 protein and HMB-45 negative "rhabdoid" malignant melanoma: a totally dedifferentiated malignant melanoma?
    Laskin WB; Knittel DR; Frame JN
    Am J Clin Pathol; 1995 Jun; 103(6):772-3. PubMed ID: 7785665
    [No Abstract]   [Full Text] [Related]  

  • 4. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
    Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
    Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant combined squamomelanocytic tumor: a clinical case.
    Wong D; Irimies A; Shkrum M; Joseph MG
    Dermatol Online J; 2013 Sep; 19(9):19610. PubMed ID: 24050285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100, HMB-45, and Melan-A negative primary melanoma.
    Shinohara MM; Deubner H; Argenyi ZB
    Dermatol Online J; 2009 Sep; 15(9):7. PubMed ID: 19930994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimens.
    Dorvault CC; Weilbaecher KN; Yee H; Fisher DE; Chiriboga LA; Xu Y; Chhieng DC
    Cancer; 2001 Oct; 93(5):337-43. PubMed ID: 11668469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic differences between uveal and cutaneous melanomas.
    Iwamoto S; Burrows RC; Kalina RE; George D; Boehm M; Bothwell MA; Schmidt R
    Arch Ophthalmol; 2002 Apr; 120(4):466-70. PubMed ID: 11934320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudovascular adenoid squamous cell carcinoma of the skin. A neoplasm that may be mistaken for angiosarcoma.
    Nappi O; Wick MR; Pettinato G; Ghiselli RW; Swanson PE
    Am J Surg Pathol; 1992 May; 16(5):429-38. PubMed ID: 1599022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous PEComa: distinctive clear cell lesions of skin.
    Liegl B; Hornick JL; Fletcher CD
    Am J Surg Pathol; 2008 Apr; 32(4):608-14. PubMed ID: 18277881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability of immunostaining using pan-melanoma cocktail, SOX10, and microphthalmia transcription factor in confirming a diagnosis of melanoma on fine-needle aspiration smears.
    Clevenger J; Joseph C; Dawlett M; Guo M; Gong Y
    Cancer Cytopathol; 2014 Oct; 122(10):779-85. PubMed ID: 24954720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiomatoid melanoma: a novel pattern of differentiation in invasive periocular desmoplastic malignant melanoma.
    Baron JA; Monzon F; Galaria N; Murphy GF
    Hum Pathol; 2000 Dec; 31(12):1520-2. PubMed ID: 11150378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
    Gleason BC; Nascimento AF
    Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage-rich epithelioid angiosarcoma mimicking malignant melanoma.
    Brightman LA; Demierre MF; Byers HR
    J Cutan Pathol; 2006 Jan; 33(1):38-42. PubMed ID: 16441410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Identification of protein S 100 and melanoma-associated antigens in a comparative study of malignant melanoma and nevus pathology].
    Monti M; Berti E; Cavicchini S; Paindelli MG; Terragni L
    G Ital Dermatol Venereol; 1985; 120(4):297-306. PubMed ID: 3899920
    [No Abstract]   [Full Text] [Related]  

  • 16. HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.
    Zubovits J; Buzney E; Yu L; Duncan LM
    Hum Pathol; 2004 Feb; 35(2):217-23. PubMed ID: 14991540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pseudovascular squamous cell carcinoma].
    Mercader P; Torrijos A; Sánchez-Carazo JL; Fortea JM
    Actas Dermosifiliogr; 2006 May; 97(4):257-9. PubMed ID: 16801019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A metastatic melanoma with an unusual immunophenotypic profile.
    Gao Z; Stanek A; Chen S
    Am J Dermatopathol; 2007 Apr; 29(2):169-71. PubMed ID: 17414440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous melanoma with myxoid features: twelve cases with differential diagnosis.
    Hitchcock MG; McCalmont TH; White WL
    Am J Surg Pathol; 1999 Dec; 23(12):1506-13. PubMed ID: 10584704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45.
    Shidham VB; Qi DY; Acker S; Kampalath B; Chang CC; George V; Komorowski R
    Am J Surg Pathol; 2001 Aug; 25(8):1039-46. PubMed ID: 11474288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.